Molecular characteristics of Staphylococcus aureus isolated from a major hospital in Lebanon
| dc.contributor.author | Harastani, Houda H. | |
| dc.contributor.author | Araj, George F. | |
| dc.contributor.author | Tokajian, Sima T. | |
| dc.contributor.department | Pathology and Laboratory Medicine | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T12:09:50Z | |
| dc.date.available | 2025-01-24T12:09:50Z | |
| dc.date.issued | 2014 | |
| dc.description.abstract | Objectives: The occurrence and dissemination of methicillin-resistant Staphylococcus aureus (MRSA) in healthcare settings and the community and its risk of being introduced into hospitals are matters of great concern. The purpose of this study was to conduct a miniaturized epidemiological analysis of S. aureus-associated infections and to characterize the isolates by a variety of molecular typing techniques. Ongoing molecular surveillance is essential to prevent S. aureus strains from becoming endemic in the Lebanese healthcare setting. Methods: A total of 132 S. aureus from different clinical specimens were isolated over a 6-month period. Characterization of the isolates was done by detection of the mecA gene, Panton-Valentine leukocidin determinant detection, staphylococcal chromosomal cassette (SCC. mec) typing of MRSA, S. aureus protein A (spa) typing, multilocus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE), and antibiogram analysis. Results: MRSA represented 30% of the isolates, with PVL being detected in 54% of MRSA and 12% of methicillin-susceptible S. aureus (MSSA). A difference between MRSA and MSSA was observed in the spa types. Clustering SCC. mec with MLST identified seven MRSA and 20 MSSA clones, with PVL-positive ST80-MRSA-IV being the dominant clone (7%), while PFGE revealed 32 groups with 80% cutoff similarity. Conclusions: Although the results of this study are based on samples collected from one hospital, the high diversity observed along with the lack of any equivalence in the genetic backgrounds of the major MSSA and MRSA clones, emphasizes the urgent need for standardized surveillance combined with the application of well-validated typing methods to assess the occurrence of MRSA and subsequently to control its spread. © 2013 The Authors. | |
| dc.identifier.doi | https://doi.org/10.1016/j.ijid.2013.10.007 | |
| dc.identifier.eid | 2-s2.0-84892855268 | |
| dc.identifier.pmid | 24280321 | |
| dc.identifier.uri | http://hdl.handle.net/10938/32145 | |
| dc.language.iso | en | |
| dc.relation.ispartof | International Journal of Infectious Diseases | |
| dc.source | Scopus | |
| dc.subject | Mlst | |
| dc.subject | Pfge | |
| dc.subject | Sccmec | |
| dc.subject | Spa typing | |
| dc.subject | St80-mrsa-iv | |
| dc.subject | Staphylococcus aureus | |
| dc.subject | Anti-bacterial agents | |
| dc.subject | Antigens, bacterial | |
| dc.subject | Bacterial proteins | |
| dc.subject | Bacterial toxins | |
| dc.subject | Bacterial typing techniques | |
| dc.subject | Cluster analysis | |
| dc.subject | Dna, bacterial | |
| dc.subject | Electrophoresis, gel, pulsed-field | |
| dc.subject | Exotoxins | |
| dc.subject | Female | |
| dc.subject | Genotype | |
| dc.subject | Humans | |
| dc.subject | Lebanon | |
| dc.subject | Leukocidins | |
| dc.subject | Male | |
| dc.subject | Methicillin-resistant staphylococcus aureus | |
| dc.subject | Microbial sensitivity tests | |
| dc.subject | Molecular epidemiology | |
| dc.subject | Multilocus sequence typing | |
| dc.subject | Staphylococcal infections | |
| dc.subject | Virulence factors | |
| dc.subject | Amoxicillin plus clavulanic acid | |
| dc.subject | Cefalotin | |
| dc.subject | Ciprofloxacin | |
| dc.subject | Clindamycin | |
| dc.subject | Cotrimoxazole | |
| dc.subject | Erythromycin | |
| dc.subject | Oxacillin | |
| dc.subject | Panton valentine leukocidin | |
| dc.subject | Rifampicin | |
| dc.subject | Staphylococcus protein a | |
| dc.subject | Teicoplanin | |
| dc.subject | Tetracycline | |
| dc.subject | Vancomycin | |
| dc.subject | Antiinfective agent | |
| dc.subject | Bacterial antigen | |
| dc.subject | Bacterial dna | |
| dc.subject | Bacterial protein | |
| dc.subject | Bacterial toxin | |
| dc.subject | Exotoxin | |
| dc.subject | Leukocidin | |
| dc.subject | Meca protein, staphylococcus aureus | |
| dc.subject | Panton-valentine leukocidin | |
| dc.subject | Streptococcal protective antigen | |
| dc.subject | Virulence factor | |
| dc.subject | Gentamicin | |
| dc.subject | Antibiotic sensitivity | |
| dc.subject | Article | |
| dc.subject | Bacterial gene | |
| dc.subject | Bacterial strain | |
| dc.subject | Bacterium isolate | |
| dc.subject | Bacterium isolation | |
| dc.subject | Controlled study | |
| dc.subject | Endemic disease | |
| dc.subject | Gene cassette | |
| dc.subject | Hospital | |
| dc.subject | Human | |
| dc.subject | Major clinical study | |
| dc.subject | Methicillin resistant staphylococcus aureus | |
| dc.subject | Methicillin susceptible staphylococcus aureus | |
| dc.subject | Molecular cloning | |
| dc.subject | Molecular typing | |
| dc.subject | Nonhuman | |
| dc.subject | Pulsed field gel electrophoresis | |
| dc.subject | Skin infection | |
| dc.subject | Soft tissue infection | |
| dc.subject | Staphylococcus infection | |
| dc.subject | Bacterium identification | |
| dc.subject | Chemistry | |
| dc.subject | Classification | |
| dc.subject | Drug effects | |
| dc.subject | Genetics | |
| dc.subject | Isolation and purification | |
| dc.subject | Microbial sensitivity test | |
| dc.subject | Microbiology | |
| dc.subject | Antibiotic resistance | |
| dc.subject | Lebanese | |
| dc.subject | Methicillin resistant staphylococcus aureus infection | |
| dc.subject | Staphylococcal skin infection | |
| dc.title | Molecular characteristics of Staphylococcus aureus isolated from a major hospital in Lebanon | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1